{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:52:20Z","timestamp":1768477940280,"version":"3.49.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.hoc.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T03:23:56Z","timestamp":1618543436000},"page":"543-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Surgery for Bladder and Upper Tract Urothelial Cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Vivek","family":"Venkatramani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipen Jaysukhlal","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib2","first-page":"1021","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib3","first-page":"2205","article-title":"Non-muscle-invasive bladder cancer (Ta,T1 and CIS)","volume":"vol. 3","author":"Stephen Jones","year":"2016"},{"key":"10.1016\/j.hoc.2021.02.005_bib4","first-page":"2242","article-title":"Transurethral and open surgery for bladder cancer","volume":"vol. 3","author":"Navai","year":"2016"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib5","first-page":"1703","article-title":"Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial","volume":"191","author":"Venkatramani","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.euf.2016.12.004","article-title":"Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer","volume":"3","author":"Kramer","year":"2017","journal-title":"Eur Urol Focus"},{"issue":"12","key":"10.1016\/j.hoc.2021.02.005_bib7","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00345-015-1568-6","article-title":"En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor","volume":"33","author":"Kramer","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2016.01.004","article-title":"\u201cEn Bloc\u201d Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study","volume":"90","author":"Hurle","year":"2016","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1089\/end.2015.0336","article-title":"Thulium Laser Endoscopic En Bloc Enucleation of Nonmuscle-Invasive Bladder Cancer","volume":"29","author":"Migliari","year":"2015","journal-title":"J\u00a0Endourol"},{"issue":"9 Pt B","key":"10.1016\/j.hoc.2021.02.005_bib10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1464-410X.2008.07966.x","article-title":"Quality control in transurethral resection of bladder tumours","volume":"102","author":"Herr","year":"2008","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","article-title":"Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies","volume":"41","author":"Brausi","year":"2002","journal-title":"Eur Urol"},{"issue":"2 Pt 2","key":"10.1016\/j.hoc.2021.02.005_bib12","first-page":"E76","article-title":"The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer","volume":"110","author":"Richterstetter","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib14","first-page":"1529","article-title":"Early complications of endoscopic treatment for superficial bladder tumors","volume":"164","author":"Collado","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib15","first-page":"810","article-title":"Complications of transurethral resection of bladder tumors: prevention, recognition and treatment","volume":"124","author":"Dick","year":"1980","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib16","first-page":"557","article-title":"Transurethral resection for muscle-invasive bladder cancer","volume":"25","author":"Kond\u00e1s","year":"1993","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib17","first-page":"1128","article-title":"Long-term consequences from bladder perforation and\/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature","volume":"161","author":"Mydlo","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib18","first-page":"68","article-title":"Intraperitoneal rupture of the urinary bladder during transurethral resection of transitional cell carcinoma","volume":"56","author":"Murshidi","year":"1988","journal-title":"Acta Urol Belg"},{"issue":"6 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib19","first-page":"2186","article-title":"A\u00a0single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2017.06.038","article-title":"Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients","volume":"73","author":"Bosschieter","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.6004\/jnccn.2013.0060","article-title":"Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Abern","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","article-title":"Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review","volume":"64","author":"Perlis","year":"2013","journal-title":"Eur Urol"},{"issue":"18","key":"10.1016\/j.hoc.2021.02.005_bib23","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019\u00a0Update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib25","author":"National Comprehensive Cancer Network"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000019859","article-title":"Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee","volume":"35","author":"van der Meijden","year":"1999","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1442-2042.2008.02241.x","article-title":"Risk of concomitant carcinoma in\u00a0situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases","volume":"16","author":"Hara","year":"2009","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in\u00a0situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"Palou","year":"2012","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.hoc.2021.02.005_bib29","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1007\/s00345-019-02673-2","article-title":"Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer","volume":"37","author":"Brant","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib30","first-page":"2223","article-title":"Management of metastatic and invasive bladder cancer","volume":"vol. 3","author":"Guzzo","year":"2016"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib31","first-page":"74","article-title":"The value of a second transurethral resection in evaluating patients with bladder tumors","volume":"162","author":"Herr","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.hoc.2021.02.005_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.6004\/jnccn.2015.0123","article-title":"Role of repeat resection in non-muscle-invasive bladder cancer","volume":"13","author":"Herr","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1089\/end.2011.0081","article-title":"Repeated white light transurethral resection of the bladder in nonmuscle-invasive urothelial bladder cancers: systematic review and meta-analysis","volume":"25","author":"Vianello","year":"2011","journal-title":"J\u00a0Endourol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib34","first-page":"1641","article-title":"The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial","volume":"175","author":"Divrik","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib36","first-page":"2134","article-title":"Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy","volume":"174","author":"Herr","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib37","first-page":"341","article-title":"The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin","volume":"191","author":"Sfakianos","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib38","first-page":"548","article-title":"Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis","volume":"197","author":"Chou","year":"2017","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.eururo.2013.07.007","article-title":"Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature","volume":"64","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib41","first-page":"135","article-title":"Improved detection of urothelial carcinoma in\u00a0situ with hexaminolevulinate fluorescence cystoscopy","volume":"171","author":"Schmidbauer","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib42","first-page":"862","article-title":"Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study","volume":"174","author":"Jocham","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib43","first-page":"68","article-title":"A\u00a0comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in\u00a0situ in patients with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2009.11.041","article-title":"Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies","volume":"57","author":"Kausch","year":"2010","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3233\/BLC-160048","article-title":"The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis","volume":"2","author":"Kamat","year":"2016","journal-title":"Bladder Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2012.01.018","article-title":"A\u00a0randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence","volume":"61","author":"Naselli","year":"2012","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2016.03.053","volume":"70","author":"Naito","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib48","doi-asserted-by":"crossref","first-page":"e0170819","DOI":"10.1371\/journal.pone.0170819","article-title":"A\u00a0meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer","volume":"12","author":"Xiong","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib49","first-page":"110","article-title":"An interval longer than 12\u00a0weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma","volume":"169","author":"S\u00e1nchez-Ortiz","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib50","first-page":"1262","article-title":"Cystectomy delay more than 3\u00a0months from initial bladder cancer diagnosis results in decreased disease specific and overall survival","volume":"175","author":"Lee","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11934-015-0548-0","article-title":"Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy","volume":"16","author":"Ahmadi","year":"2015","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib52","first-page":"470","article-title":"Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial","volume":"201","author":"Ritch","year":"2019","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib53","first-page":"552","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO Guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib54","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines","author":"Witjes","year":"2020","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.hoc.2021.02.005_bib55","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00345-015-1482-y","article-title":"Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients","volume":"33","author":"Colombo","year":"2015","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib56","first-page":"64","article-title":"Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial","volume":"193","author":"Jacobs","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib57","first-page":"1323","article-title":"Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution","volume":"172","author":"Kessler","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib58","first-page":"1250","article-title":"Prostate sparing cystectomy for bladder cancer: 20-year single center experience","volume":"191","author":"Mertens","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib59","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.urology.2013.08.093","article-title":"Seminal-sparing cystectomy: technical evolution and results over a 20-year period","volume":"83","author":"Muto","year":"2014","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib60","first-page":"2170","article-title":"Oncological evaluation of prostate sparing cystectomy: the Montsouris long-term results","volume":"179","author":"Rozet","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"9","key":"10.1016\/j.hoc.2021.02.005_bib61","doi-asserted-by":"crossref","first-page":"539.e17-29","DOI":"10.1016\/j.urolonc.2017.04.013","article-title":"Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: A systematic review","volume":"35","author":"Hern\u00e1ndez","year":"2017","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2013.02.004","article-title":"Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: a report on 15 cases with long term follow-up","volume":"39","author":"Ali-El-Dein","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib63","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/GRF.0000000000000318","article-title":"Ovarian Cancer Prevention in High-risk Women","volume":"60","author":"Temkin","year":"2017","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib64","first-page":"758","article-title":"The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results","volume":"149","author":"Lerner","year":"1993","journal-title":"J\u00a0Urol"},{"issue":"14","key":"10.1016\/j.hoc.2021.02.005_bib65","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.2004.11.024","article-title":"Surgical factors influence bladder cancer outcomes: a cooperative group report","volume":"22","author":"Herr","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib66","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib67","first-page":"873","article-title":"Outcome after radical cystectomy with limited or extended pelvic lymph node dissection","volume":"179","author":"Dhar","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1442-2042.2011.02887.x","article-title":"Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival","volume":"19","author":"Jensen","year":"2012","journal-title":"Int J Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib69","first-page":"2015","article-title":"Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall","volume":"160","author":"Poulsen","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib70","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1442-2042.2012.03148.x","article-title":"Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy","volume":"20","author":"Simone","year":"2013","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00345-008-0366-9","article-title":"Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?","volume":"27","author":"Holmer","year":"2009","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib72","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2014.07.046","article-title":"Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy","volume":"66","author":"Froehner","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib73","first-page":"1295","article-title":"Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer","volume":"167","author":"Herr","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib74","first-page":"946","article-title":"Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base","volume":"169","author":"Konety","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.hoc.2021.02.005_bib75","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/cncr.22250","article-title":"Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?","volume":"107","author":"Koppie","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib76","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.urology.2012.03.070","article-title":"Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients","volume":"80","author":"Morgan","year":"2012","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.hoc.2021.02.005_bib77","doi-asserted-by":"crossref","first-page":"425.e15-23","DOI":"10.1016\/j.urolonc.2015.06.005","article-title":"Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study","volume":"33","author":"Siemens","year":"2015","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib78","first-page":"35","article-title":"Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density","volume":"170","author":"Stein","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib79","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/cncr.23474","article-title":"The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy","volume":"112","author":"Wright","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib80","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial","volume":"75","author":"Gschwend","year":"2019","journal-title":"Eur Urol"},{"issue":"6 Suppl 4","key":"10.1016\/j.hoc.2021.02.005_bib81","first-page":"S211","article-title":"Management of the urethra in urothelial bladder cancer","volume":"3","author":"Kanaroglou","year":"2009","journal-title":"Can Urol Assoc J"},{"issue":"3 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib82","first-page":"756","article-title":"Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature","volume":"178","author":"Stein","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000019550","article-title":"Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy","volume":"33","author":"Lebret","year":"1998","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib84","first-page":"2120","article-title":"Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center","volume":"157","author":"Chen","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bju.12121","article-title":"Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes","volume":"113","author":"Lee","year":"2014","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib86","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2007.09.008","article-title":"Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions","volume":"53","author":"Nieuwenhuijzen","year":"2008","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib87","first-page":"1729","article-title":"Quality of life after cystectomy and urinary diversion: an evidence based analysis","volume":"174","author":"Gerharz","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2015.12.079","article-title":"Recent trends in postcystectomy health-related quality of life (qol) favors neobladder diversion: systematic review of the literature","volume":"93","author":"Ghosh","year":"2016","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib89","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bju.12919","article-title":"Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?","volume":"116","author":"Al Hussein Al Awamlh","year":"2015","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib90","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bju.13462","article-title":"Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy","volume":"118","author":"Longo","year":"2016","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib91","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1464-410X.2008.07877.x","article-title":"Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease","volume":"102","author":"Guzzo","year":"2008","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib92","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.urolonc.2009.04.017","article-title":"Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer","volume":"29","author":"Yafi","year":"2011","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib93","first-page":"96","article-title":"Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance","volume":"179","author":"Tran","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib94","first-page":"2632","article-title":"Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?","volume":"182","author":"Volkmer","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"9","key":"10.1016\/j.hoc.2021.02.005_bib95","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/cncr.22238","article-title":"Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer","volume":"107","author":"Raj","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000092928","article-title":"Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib97","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000209363","article-title":"The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder","volume":"82","author":"Cho","year":"2009","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib98","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2004.06.012","article-title":"Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring","volume":"64","author":"Nieder","year":"2004","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib99","first-page":"1163","article-title":"Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients","volume":"173","author":"Stein","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib100","first-page":"2052","article-title":"Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer","volume":"181","author":"Stein","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib101","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejso.2008.03.005","article-title":"Oncological outcome after radical cystectomy and orthotopic bladder substitution in women","volume":"35","author":"Ali-El-Dein","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib102","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.eururo.2011.08.030","article-title":"Risk factors and outcomes of urethral recurrence following radical cystectomy","volume":"60","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib103","first-page":"909","article-title":"Positive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution","volume":"201","author":"Roth","year":"2019","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib104","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2003.05.101","article-title":"Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy","volume":"21","author":"Madersbacher","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2021.02.005_bib105","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1464-410X.2009.08625.x","article-title":"Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome","volume":"104","author":"Manoharan","year":"2009","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib106","first-page":"486","article-title":"Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era","volume":"176","author":"Hautmann","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib107","first-page":"121","article-title":"Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later","volume":"180","author":"Ghoneim","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib108","first-page":"2414","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib109","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/bju.12566","article-title":"Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base","volume":"114","author":"Nielsen","year":"2014","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib110","first-page":"2139","article-title":"Volume outcomes of cystectomy--is it the surgeon or the setting?","volume":"188","author":"Morgan","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib111","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00345-006-0061-7","article-title":"Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure","volume":"24","author":"Stein","year":"2006","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib112","first-page":"990","article-title":"Lessons learned from 1,000 neobladders: the 90-day complication rate","volume":"184","author":"Hautmann","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib113","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","article-title":"Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients","volume":"61","author":"Hautmann","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00345-010-0626-3","article-title":"Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study","volume":"29","author":"Porter","year":"2011","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2008.07.031","article-title":"Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","volume":"55","author":"Shabsigh","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib116","first-page":"985","article-title":"Long-term outcome of ileal conduit diversion","volume":"169","author":"Madersbacher","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib117","first-page":"161","article-title":"Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned","volume":"176","author":"Studer","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib118","first-page":"2281","article-title":"Use of intestinal segments in urinary diversion","volume":"vol. 3","author":"Dahl","year":"2016"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib119","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.eururo.2016.05.020","article-title":"Enhanced Recovery After Robot-assisted Radical Cystectomy: EAU Robotic Urology Section Scientific Working Group Consensus View","volume":"70","author":"Collins","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00268-012-1772-0","article-title":"Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(\u00ae)) Society recommendations","volume":"37","author":"Gustafsson","year":"2013","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib121","first-page":"1209","article-title":"Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway","volume":"194","author":"Xu","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib122","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.eururo.2014.02.036","article-title":"Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial","volume":"66","author":"Lee","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib123","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.urology.2007.07.048","article-title":"Gum chewing stimulates bowel motility in patients undergoing radical cystectomy with urinary diversion","volume":"70","author":"Kouba","year":"2007","journal-title":"Urology"},{"issue":"10139","key":"10.1016\/j.hoc.2021.02.005_bib124","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/S0140-6736(18)30996-6","article-title":"Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial","volume":"391","author":"Parekh","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib125","first-page":"522","article-title":"Predictors of recurrence, and progression-free and overall survival following open versus robotic radical cystectomy: analysis from the RAZOR trial with a 3-year followup","volume":"203","author":"Venkatramani","year":"2020","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib126","first-page":"474","article-title":"Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy","volume":"189","author":"Parekh","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib127","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.eururo.2009.10.024","article-title":"Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results","volume":"57","author":"Nix","year":"2010","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJMc1405213","article-title":"A\u00a0randomized trial of robot-assisted laparoscopic radical cystectomy","volume":"371","author":"Bochner","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2021.02.005_bib129","doi-asserted-by":"crossref","first-page":"e020500","DOI":"10.1136\/bmjopen-2017-020500","article-title":"Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study","volume":"8","author":"Catto","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.eururo.2008.08.027","article-title":"Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy","volume":"55","author":"Solsona","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2001.19.1.89","article-title":"Transurethral resection of muscle-invasive bladder cancer: 10-year outcome","volume":"19","author":"Herr","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib132","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.seminoncol.2012.08.011","article-title":"Urachal adenocarcinoma: a clinician\u2019s guide for treatment","volume":"39","author":"Siefker-Radtke","year":"2012","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib133","first-page":"1761","article-title":"Carcinoma in a bladder diverticulum: presentation and treatment outcome","volume":"170","author":"Golijanin","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2021.02.005_bib134","first-page":"1365","article-title":"Urothelial tumors of the upper urinary tract and ureter","volume":"2","author":"Smith","year":"2016"},{"key":"10.1016\/j.hoc.2021.02.005_bib135","article-title":"European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020\u00a0Update","author":"Roupr\u00eat","year":"2020","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib136","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib137","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.crad.2009.11.003","article-title":"MR urography versus retrograde pyelography\/ureteroscopy for the exclusion of upper urinary tract malignancy","volume":"65","author":"Lee","year":"2010","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib138","first-page":"524","article-title":"Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria","volume":"181","author":"Wang","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib139","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/21681805.2017.1295102","article-title":"Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters","volume":"51","author":"Malm","year":"2017","journal-title":"Scand J Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib141","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bju.14053","article-title":"Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis","volume":"121","author":"Guo","year":"2018","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib142","first-page":"783","article-title":"Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma","volume":"161","author":"Hendin","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib143","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.13935","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis","volume":"120","author":"Marchioni","year":"2017","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib144","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2013.12.007","article-title":"A\u00a0new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs","volume":"66","author":"Roupr\u00eat","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrurol.2015.24","article-title":"Risk-adapted strategy for the kidney-sparing management of upper tract tumours","volume":"12","author":"Seisen","year":"2015","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib146","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","article-title":"Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel","volume":"70","author":"Seisen","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib147","first-page":"1173","article-title":"Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys","volume":"164","author":"Chen","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib148","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","article-title":"Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib149","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","article-title":"Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2006.07.019","article-title":"Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection","volume":"51","author":"Roupr\u00eat","year":"2007","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.hoc.2021.02.005_bib151","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1464-410X.2012.10960.x","article-title":"Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study","volume":"110","author":"Colin","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib152","first-page":"1324","article-title":"Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter","volume":"183","author":"Jeldres","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"7","key":"10.1016\/j.hoc.2021.02.005_bib153","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.urolonc.2019.02.004","article-title":"Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature","volume":"37","author":"Foerster","year":"2019","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib154","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1470-2045(20)30147-9","article-title":"Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial","volume":"21","author":"Kleinmann","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib155","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib156","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.euf.2017.10.003","article-title":"Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review","volume":"5","author":"Peyronnet","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib157","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","article-title":"Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"56","author":"Simone","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib158","first-page":"1561","article-title":"Oncologic outcomes following robot-assisted laparoscopic nephroureterectomy with bladder cuff excision for upper tract urothelial carcinoma","volume":"194","author":"Aboumohamed","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"9","key":"10.1016\/j.hoc.2021.02.005_bib159","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1245\/s10434-018-6557-8","article-title":"Robotic-assisted surgery for upper tract urothelial carcinoma: a comparative survival analysis","volume":"25","author":"Clements","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.eururo.2009.12.032","article-title":"Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma","volume":"57","author":"Li","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.hoc.2021.02.005_bib161","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib162","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1464-410X.1988.tb06377.x","article-title":"Modified nephro-ureterectomy. Long-term follow-up with particular reference to subsequent bladder tumours","volume":"61","author":"Abercrombie","year":"1988","journal-title":"Br J Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib163","first-page":"565","article-title":"Intussusception ureterectomy: a method of removal of the ureteral stump at time of nephrectomy without an additional incision","volume":"97","author":"McDONALD","year":"1953","journal-title":"Surg Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib164","first-page":"430","article-title":"A\u00a0novel technique for management of the en bloc bladder cuff and distal ureter during laparoscopic nephroureterectomy","volume":"161","author":"Gill","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ucl.2011.07.012","article-title":"The emerging role of lymphadenectomy in upper tract urothelial carcinoma","volume":"38","author":"Weight","year":"2011","journal-title":"Urol Clin North Am"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib166","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/iju.12338","article-title":"Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study","volume":"21","author":"Kondo","year":"2014","journal-title":"Int J Urol"},{"issue":"8","key":"10.1016\/j.hoc.2021.02.005_bib167","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1442-2042.2012.03009.x","article-title":"Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract","volume":"19","author":"Kondo","year":"2012","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.hoc.2021.02.005_bib168","first-page":"1567","article-title":"Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates","volume":"194","author":"Matin","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2021.02.005_bib169","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.eururo.2007.04.070","article-title":"Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival","volume":"52","author":"Brausi","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.hoc.2021.02.005_bib170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.euf.2017.09.015","article-title":"Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer","volume":"5","author":"Dominguez-Escrig","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"4 Pt 1","key":"10.1016\/j.hoc.2021.02.005_bib171","first-page":"1212","article-title":"Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract","volume":"178","author":"Kondo","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib172","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.hoc.2021.02.005_bib173","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000350508","article-title":"Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis","volume":"91","author":"Fang","year":"2013","journal-title":"Urol Int"},{"issue":"11","key":"10.1016\/j.hoc.2021.02.005_bib174","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ito","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2021.02.005_bib175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882100023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882100023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:16:21Z","timestamp":1760184981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985882100023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S088985882100023X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.02.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgery for Bladder and Upper Tract Urothelial Cancer","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}